Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 2/20 | 0.59 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | MITF | O75030 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10028358 | 1.00 | CYP19A1 (0.59) | CYP19A1EPHX1ALDH1A1NPSR1TSHR | |
| SCHEMBL10062430 | 1.00 | CYP19A1 (0.59) | CYP19A1EPHX1ALDH1A1NPSR1TSHR | |
| SCHEMBL14032266 | 1.00 | CYP19A1 (0.59) | CYP19A1EPHX1ALDH1A1NPSR1TSHR | |
| SCHEMBL12191998 | 1.00 | CYP19A1 (0.59) | CYP19A1EPHX1ALDH1A1NPSR1TSHR | |
| SCHEMBL23255563 | 0.87 | CYP19A1 (0.61) | CYP19A1EPHX1ALDH1A1NPSR1TSHR | |
| SCHEMBL1665360 | 0.87 | CYP19A1 (0.61) | CYP19A1EPHX1ALDH1A1NPSR1TSHR | |
| SCHEMBL3424391 | 0.87 | CYP19A1 (0.61) | CYP19A1EPHX1ALDH1A1NPSR1TSHR | |
| SCHEMBL21610695 | 0.87 | CYP19A1 (0.61) | CYP19A1EPHX1ALDH1A1NPSR1TSHR | |
| SCHEMBL7991614 | 0.87 | CYP19A1 (0.61) | CYP19A1EPHX1ALDH1A1NPSR1TSHR | |
| SCHEMBL7991612 | 0.87 | CYP19A1 (0.61) | CYP19A1EPHX1ALDH1A1NPSR1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112075427-A | Compound seed treating agent, preparation method thereof and seed pretreatment method thereof | 哈尔滨市农业科学院 | 2020-12-15 | — | — | CN | claimed |
| CN-111518032-A | Preparation method of Gboxin | 武汉珞石科技有限公司 | 2020-08-11 | — | — | CN | claimed |
| CN-113956170-A | Preparation method of efficient gemini quaternary ammonium salt bactericide for oil field | 常州大学 | 2022-01-21 | — | — | CN | disclosed |
| CN-112075427-A | Compound seed treating agent, preparation method thereof and seed pretreatment method thereof | 哈尔滨市农业科学院 | 2020-12-15 | — | — | CN | disclosed |
| CN-111518032-A | Preparation method of Gboxin | 武汉珞石科技有限公司 | 2020-08-11 | — | — | CN | disclosed |
| CN-111518032-A | Preparation method of Gboxin | 武汉珞石科技有限公司 | 2020-08-11 | — | — | CN | disclosed |
| EP-2058300-B1 | SUCCINIC ACID DIESTER DERIVATIVE, PROCESS FOR PRODUCTION THEREOF, AND USE OF THE DERIVATIVE IN THE PRODUCTION OF PHARMACEUTICAL PREPARATION | DAINIPPON SUMITOMO PHARMA CO (JP) | 2013-01-09 | — | — | EP | disclosed |
| EP-1348696-B1 | Use of optically active clausenamides for the preparation of pharmaceutical compositions, pharmaceutical compositions containing the same | INST MATERIA MEDICA CAMS (CN) | 2012-02-01 | — | — | EP | disclosed |
| US-8106230-B2 | Succinic acid diester derivative, process for production thereof, and use of the derivative in the production of pharmaceutical preparation | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2012-01-31 | — | — | US | disclosed |
| US-8030486-B2 | Succinic acid diester derivative, process for production thereof, and use of the derivative in the production of pharmaceutical preparation | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2011-10-04 | — | — | US | disclosed |
| US-20110046373-A1 | SUCCINIC ACID DIESTER DERIVATIVE, PROCESS FOR PRODUCTION THEREOF, AND USE OF THE DERIVATIVE IN THE PRODUCTION OF PHARMACEUTICAL PREPARATION | INAGAKI TAKASHI | 2011-02-24 | — | — | US | disclosed |
| EP-2058300-A1 | SUCCINIC ACID DIESTER DERIVATIVE, PROCESS FOR PRODUCTION THEREOF, AND USE OF THE DERIVATIVE IN THE PRODUCTION OF PHARMACEUTICAL PREPARATION | Dainippon Sumitomo Pharma Co., Ltd. (JP) | 2009-05-13 | — | — | EP | disclosed |
| CN-101338287-A | Bacillus subtilis esterase and application thereof for producing 1-menthol | UNIV EAST CHINA SCIENCE & TECH (CN) | 2009-01-07 | — | — | CN | disclosed |
| CN-1956943-A | Catalytic asymmetric desymmetrization of prochiral and meso cyclic anhydrides | UNIV BRANDEIS (US) | 2007-05-02 | — | — | CN | disclosed |
| US-6787564-B2 | FOR TREATING HYPOXIA PROTECTIVE, NOOTROPIC AND NEURODEGENERATIVE DISEASES (CERBRAL ISCHEMIA, ALZHEIMER'S DISEASE, AND VASCULAR DEMENTIA) | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2004-09-07 | — | — | US | disclosed |
| US-20030207935-A1 | Novel optically active clausenamides, process of the preparation thereof, pharmaceutical composition containing the same and their medical use | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES | 2003-11-06 | — | — | US | disclosed |
| EP-1348696-A1 | Optically active clausenamides, process of the preparation thereof, pharmaceutical composition containing the same and their medical use | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2003-10-01 | — | — | EP | disclosed |
| CN-1192776-A | Betaine esters capable of liberating alcohols | PROCTER & GAMBLE (US) | 1998-09-09 | — | — | CN | disclosed |
| EP-0752465-A1 | Betaine esters for delivery of alcohols | THE PROCTER & GAMBLE COMPANY (US) | 1997-01-08 | — | — | EP | disclosed |
| WO-1996038528-A1 | BETAINE ESTERS FOR DELIVERY OF ALCOHOLS | THE PROCTER & GAMBLE COMPANY (US) | 1996-12-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110046373-A1 | SUCCINIC ACID DIESTER DERIVATIVE, PROCESS FOR PRODUCTION THEREOF, AND USE OF THE DERIVATIVE IN THE PRODUCTION OF PHARMACEUTICAL PREPARATION | SUCNR1, DLST, SHMT2 | CYP19A1 533/4885EPHX1 3382/4885ALDH1A1 486/4885 |
| US-20030207935-A1 | Novel optically active clausenamides, process of the preparation thereof, pharmaceutical composition containing the same and their medical use | HIF1AN, HIF1A, CLN6 | CYP19A1 699/4885EPHX1 455/4885ALDH1A1 1464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.